Sofwave Medical Ltd (SOFW) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Sofwave Medical Ltd (SOFW) has a cash flow conversion efficiency ratio of -0.014x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA-494.69K ≈ $-1.33K USD) by net assets (ILA35.33 Million ≈ $94.73K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Sofwave Medical Ltd - Cash Flow Conversion Efficiency Trend (2019–2025)
This chart illustrates how Sofwave Medical Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does Sofwave Medical Ltd carry for a breakdown of total debt and financial obligations.
Sofwave Medical Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Sofwave Medical Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Guangdong Anjubao Digital Tech
SHE:300155
|
0.000x |
|
Banco Santander Brasil SA
BA:BSBR
|
0.309x |
|
HCM II Acquisition Corp
NASDAQ:HOND
|
-0.002x |
|
Cogobuy Group
F:7C3
|
-0.057x |
|
Shanghai Menon Animal Nutrition Technology Co. Ltd.
SHE:301156
|
0.051x |
|
Holcim Argentina SA
BA:HARG
|
0.147x |
|
Zhejiang Shengda Pharm
SHG:603079
|
0.028x |
|
Dongnan Electronics Co. Ltd. A
SHE:301359
|
N/A |
Annual Cash Flow Conversion Efficiency for Sofwave Medical Ltd (2019–2025)
The table below shows the annual cash flow conversion efficiency of Sofwave Medical Ltd from 2019 to 2025. For the full company profile with market capitalisation and key ratios, see Sofwave Medical Ltd (SOFW) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ILA32.72 Million ≈ $87.71K |
ILA15.08 Million ≈ $40.44K |
0.461x | +571.96% |
| 2024-12-31 | ILA24.53 Million ≈ $65.75K |
ILA-2.40 Million ≈ $-6.42K |
-0.098x | +59.19% |
| 2023-12-31 | ILA26.34 Million ≈ $70.62K |
ILA-6.31 Million ≈ $-16.91K |
-0.239x | +27.61% |
| 2022-12-31 | ILA32.34 Million ≈ $86.70K |
ILA-10.69 Million ≈ $-28.67K |
-0.331x | -636.46% |
| 2021-12-31 | ILA46.70 Million ≈ $125.21K |
ILA-2.10 Million ≈ $-5.62K |
-0.045x | +98.57% |
| 2020-12-31 | ILA1.53 Million ≈ $4.11K |
ILA-4.80 Million ≈ $-12.88K |
-3.133x | -336.15% |
| 2019-12-31 | ILA4.12 Million ≈ $11.03K |
ILA-2.96 Million ≈ $-7.92K |
-0.718x | -- |
About Sofwave Medical Ltd
SofWave Medical Ltd. engages in the development, production, marketing, and distribution of non-invasive medical technology for skin firming and rejuvenation, tissue renewal, treatment of muscle, aging, and other physiological change in Israel, the United States, Europe, Southeast Asia, the Middle East, and internationally. The company offers an ultrasound technology that induces coagulation and … Read more